- CFO Spotlights
- Profiles
- Richard S. Lindahl
Profile
Richard S. Lindahl
Executive Vice President, Chief Financial Officer (Principal Financial and Accounting Officer), Emergent BioSolutions Inc.
A later filing names a successor. First published here October 28, 2026; built from records as of October 28, 2026.
Richard S. Lindahl signed the annual report of Emergent BioSolutions Inc. on Form 10-K as Executive Vice President, Chief Financial Officer (Principal Financial and Accounting Officer), filed February 27, 2026.1 A later filing by Emergent BioSolutions Inc., made on October 16, 2026, names Frank Vargo as its interim chief financial officer; the record holds no filing that reports the end of Richard S. Lindahl's tenure.
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| Emergent BioSolutions Inc. (EBS) Pharmaceutical Preparations | Executive Vice President, Chief Financial Officer (Principal Financial and Accounting Officer) | A later filing names a successor Frank Vargo, filed October 16, 2026 (filing) |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- February 27, 202610-K filed
Richard S. Lindahl signed the annual report of Emergent BioSolutions Inc. on Form 10-K as Executive Vice President, Chief Financial Officer (Principal Financial and Accounting Officer), filed February 27, 2026.
/s/Richard S. Lindahl Richard S. Lindahl Executive Vice President, Chief Financial Officer (Principal Financial and Accounting Officer)
[1] Annual report on Form 10-K by Emergent BioSolutions Inc., filed with the SEC on February 27, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Annual report on Form 10-K, Emergent BioSolutions Inc.. U.S. Securities and Exchange Commission, EDGAR, filed February 27, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or Richard S. Lindahl wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.